Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Johnson & Johnson : to Participate in the 2018 Wells Fargo 13th Annual Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2018 | 11:48am CEST

New Brunswick - Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Wells Fargo 13th Annual Healthcare Conference on Thursday, Sept. 6th, at The Westin Boston Waterfront in Boston, MA. Alex Gorsky, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 9:45 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately two hours after the live webcast.

Contact:

Ernie Knewitz

Tel: (732) 524-6623

(C) 2018 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
08/14JOHNSON & JOHNSON : to Participate in the 2018 Wells Fargo 13th Annual Healthcar..
AQ
08/14JOHNSON & JOHNSON : to Participate in Barclays Global Consumer Staples Conferenc..
AQ
08/14JOHNSON & JOHNSON : Janssen Submits U.S. & EU Regulatory Applications Seeking Ap..
AQ
08/14JOHNSON & JOHNSON : Announces Chris DelOrefice as Vice President of Investor Rel..
AQ
08/13HANDICARE : appoints Staffan Ternström as new President and CEO
AQ
08/13JOHNSON & JOHNSON : 7 Questions for Alex Gorsky About Johnson & Johnson's Ground..
PU
08/11JOHNSON & JOHNSON : Navy Seeks Medical Plasma Equipment in North Carolina
AQ
08/10JOHNSON & JOHNSON : Janssen Submits U.S. & EU Regulatory Applications Seeking Ap..
AQ
08/10EMERGENT BIOSOLUTIONS : acquiring vaccine company PaxVax
AQ
08/10JOHNSON & JOHNSON : Summit Health recognized for role of women on executive team
AQ
More news
News from SeekingAlpha
08/148 DIVIDEND INCREASES : August 6-10, 2018 
08/13TEXAS INSTRUMENTS : Great Total Return With Dividend Increase Coming In Septembe.. 
08/13Johnson & Johnson Navigating Through Litigation Overhang 
08/13DIVIDEND SENSEI'S PORTFOLIO UPDATE 4 : Overcoming Adversity And Soaring To New H.. 
08/13IYH : Positive Demographic Trends For Healthcare 
Financials ($)
Sales 2018 81 133 M
EBIT 2018 25 227 M
Net income 2018 16 036 M
Debt 2018 11 243 M
Yield 2018 2,75%
P/E ratio 2018 19,41
P/E ratio 2019 17,04
EV / Sales 2018 4,46x
EV / Sales 2019 4,22x
Capitalization 351 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 143 $
Spread / Average Target 9,9%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Charles O. Prince Independent Director
William David Perez Independent Director
Anne M. Mulcahy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-7.31%350 770
PFIZER12.40%239 423
NOVARTIS-1.07%209 596
ROCHE HOLDING LTD.-2.84%207 317
MERCK AND COMPANY18.11%175 715
AMGEN12.48%125 843